Your session is about to expire
← Back to Search
Quantitative for Latent Tuberculosis
N/A
Waitlist Available
Research Sponsored by Kent Hospital, Rhode Island
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six-month echo course
Awards & highlights
Study Summary
This trial will help researchers understand how to better educate primary care providers on testing and treating latent tuberculosis infection, in order to improve care and outcomes for patients.
Eligible Conditions
- Latent Tuberculosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six-month echo course
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six-month echo course
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility: Participant Attendance
Feasibility: Participant Retention
Impact: Procedural knowledge
+4 moreSecondary outcome measures
Feasibility: Case Submission
Feasibility: Communication with ECHO hub
Feasibility: Connectivity
+3 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Retrospective chart reviewExperimental Treatment1 Intervention
Pilot a retrospective electronic medical record (EMR) data review to examine RI primary care providers' testing and treatment before and after ECHO implementation and evaluate the model's reach. In Aim 3, data will be retrospectively extracted from two participants' clinics to research RI primary care providers' testing and treatment patterns before and after the ECHO course. The two clinics will be identified once Aim 2 is completed.
Group II: QuantitativeExperimental Treatment1 Intervention
Specific Aim 2: Design and evaluate an evidence-based telementoring intervention (ECHO model) that addresses the identified TB infection gaps in Aim 1, and evaluate this model for feasibility as well as its impact on primary care team member knowledge and TB infection testing and treatment in RI. 20 primary care team members will be recruited to participate in a virtual six-month TB infection ECHO course. Participants will complete quantitative surveys before and after the course as well as post-session surveys following each session. Survey questions will assess feasibility measures related to process, resources, and management and impact measures related to learning and performance. Paired data from pre- and post-course surveys will be analyzed accordingly depending on the distribution of results.
Group III: QualitativeActive Control1 Intervention
Specific Aim 1: Explore the specific knowledge, attitudinal, and skills gaps to TB infection testing and treatment among primary care team members in RI through qualitative key informant interviews.
In Aim 1, 30 primary care team members from the Brown Family Medicine and Care New England networks will be purposively sampled to undergo key informant interviews regarding TB infection testing and treatment knowledge, attitudinal, and skill gaps. Questions will be asked to ascertain gaps throughout the entire latent TB infection care cascade. The results from Aim 1 will be used to design the survey instrument and the curriculum for an innovative, telementoring program (TB infection ECHO).
Find a Location
Who is running the clinical trial?
National Institute of General Medical Sciences (NIGMS)NIH
269 Previous Clinical Trials
247,082 Total Patients Enrolled
Kent Hospital, Rhode IslandLead Sponsor
2 Previous Clinical Trials
406 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger